Curis | CRIS - Passifs Courants





Passifs Courants Changement Date
Alaunos Therapeutics USD 595K 218K 2026-03
Amgen USD 24.96B 534M 2026-03
AstraZeneca USD 32.57B 1.95B 2026-03
Bayer EUR 33.46B 875M 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
CSL USD 4.61B 207M 2025-12
Curis USD 14.08M 5.3M 2025-12
Eli Lilly USD 36.63B 1.41B 2026-03
Exelixis USD 370.98M 34.67M 2026-03
Gilead Sciences USD 9.48B 2.34B 2026-03
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
Incyte USD 1.49B 25.52M 2026-03
Merck USD 26.94B 1.38B 2026-03
Novartis USD 31.37B 4.1B 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 30.01B 1.66B 2026-03
Takeda JPY 2.43T 180.65B 2026-03
TG Therapeutics USD 187.11M 33.35M 2026-03
Verastem USD 72.27M 12.56M 2025-12
Xoma USD 28.3M 6.81M 2025-09